UFP Technologies, Inc. (UFPT)
USD 193.62
(-8.15%)
USD 193.62
(-8.15%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 72.74 Million USD | 116.96% |
| 2022 | 56.35 Million USD | 11.32% |
| 2021 | 30.04 Million USD | 79.01% |
| 2020 | 25.45 Million USD | -31.9% |
| 2019 | 32.88 Million USD | 14.99% |
| 2018 | 28.48 Million USD | 85.39% |
| 2017 | 17.39 Million USD | 30.93% |
| 2016 | 18.02 Million USD | -41.67% |
| 2015 | 18.29 Million USD | 13.74% |
| 2014 | 17.4 Million USD | -23.34% |
| 2013 | 21.49 Million USD | 4.53% |
| 2012 | 19.59 Million USD | -5.69% |
| 2011 | 17.65 Million USD | 1.66% |
| 2010 | 17.37 Million USD | 112.35% |
| 2009 | 11.07 Million USD | -35.49% |
| 2008 | 11.46 Million USD | 26.42% |
| 2007 | 10.06 Million USD | 23.47% |
| 2006 | 8.11 Million USD | 60.02% |
| 2005 | 5.1 Million USD | 24.5% |
| 2004 | 4.65 Million USD | 1.77% |
| 2003 | 2.6 Million USD | 27.02% |
| 2002 | 3.15 Million USD | 96.94% |
| 2001 | 559.7 Thousand USD | -75.83% |
| 2000 | 6.46 Million USD | 22.75% |
| 1999 | 5.6 Million USD | 5.88% |
| 1998 | 5.1 Million USD | 6.25% |
| 1997 | 4.8 Million USD | 33.33% |
| 1996 | 3.7 Million USD | 50.0% |
| 1995 | 2.4 Million USD | 200.0% |
| 1994 | -100 Thousand USD | -46.67% |
| 1993 | 1.4 Million USD | -6.25% |
| 1992 | 1.6 Million USD | -23.81% |
| 1991 | 1.8 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 28.72 Million USD | 29.59% |
| 2024 Q2 | 22.16 Million USD | 15.61% |
| 2024 Q1 | 19.16 Million USD | 20.03% |
| 2023 Q2 | 17.36 Million USD | -6.38% |
| 2023 Q1 | 18.54 Million USD | 55.77% |
| 2023 FY | - USD | 116.96% |
| 2023 Q3 | 18.15 Million USD | 4.52% |
| 2023 Q4 | 15.97 Million USD | -12.01% |
| 2022 FY | - USD | 11.32% |
| 2022 Q4 | 11.9 Million USD | -13.74% |
| 2022 Q3 | 13.8 Million USD | -12.18% |
| 2022 Q2 | 15.72 Million USD | 119.09% |
| 2022 Q1 | 7.17 Million USD | -0.51% |
| 2021 Q1 | 5.3 Million USD | 4.06% |
| 2021 Q4 | 7.21 Million USD | -0.43% |
| 2021 FY | - USD | 79.01% |
| 2021 Q3 | 7.24 Million USD | -12.4% |
| 2021 Q2 | 8.26 Million USD | 56.0% |
| 2020 FY | - USD | -31.9% |
| 2020 Q1 | 4.74 Million USD | -29.68% |
| 2020 Q2 | 3.24 Million USD | -31.51% |
| 2020 Q3 | 3.73 Million USD | 15.02% |
| 2020 Q4 | 5.09 Million USD | 36.29% |
| 2019 Q1 | 5.25 Million USD | -4.53% |
| 2019 Q2 | 6.57 Million USD | 25.11% |
| 2019 Q3 | 6.13 Million USD | -6.6% |
| 2019 Q4 | 6.74 Million USD | 9.91% |
| 2019 FY | - USD | 14.99% |
| 2018 Q4 | 5.5 Million USD | -6.67% |
| 2018 FY | - USD | 85.39% |
| 2018 Q3 | 5.89 Million USD | 7.79% |
| 2018 Q1 | 4.62 Million USD | 123.72% |
| 2018 Q2 | 5.46 Million USD | 18.33% |
| 2017 Q4 | 2.06 Million USD | -17.36% |
| 2017 FY | - USD | 30.93% |
| 2017 Q2 | 3.83 Million USD | 19.87% |
| 2017 Q1 | 3.19 Million USD | 18.25% |
| 2017 Q3 | 2.5 Million USD | -34.73% |
| 2016 Q1 | 3.3 Million USD | -21.4% |
| 2016 FY | - USD | -41.67% |
| 2016 Q3 | 769 Thousand USD | -77.64% |
| 2016 Q4 | 2.7 Million USD | 251.37% |
| 2016 Q2 | 3.43 Million USD | 3.93% |
| 2015 Q4 | 4.21 Million USD | -28.92% |
| 2015 FY | - USD | 13.74% |
| 2015 Q2 | 3.54 Million USD | -7.0% |
| 2015 Q1 | 3.81 Million USD | 25.5% |
| 2015 Q3 | 5.92 Million USD | 66.99% |
| 2014 Q4 | 3.03 Million USD | -22.34% |
| 2014 Q3 | 3.91 Million USD | 25.82% |
| 2014 Q2 | 3.11 Million USD | -2.66% |
| 2014 Q1 | 3.19 Million USD | -40.0% |
| 2014 FY | - USD | -23.34% |
| 2013 Q2 | 4.64 Million USD | 57.1% |
| 2013 FY | - USD | 4.53% |
| 2013 Q1 | 2.95 Million USD | -35.77% |
| 2013 Q3 | 5.48 Million USD | 18.19% |
| 2013 Q4 | 5.32 Million USD | -2.99% |
| 2012 Q1 | 4.36 Million USD | -12.88% |
| 2012 Q3 | 4.07 Million USD | -5.48% |
| 2012 Q4 | 4.6 Million USD | 13.07% |
| 2012 Q2 | 4.3 Million USD | -1.46% |
| 2012 FY | - USD | -5.69% |
| 2011 FY | - USD | 1.66% |
| 2011 Q4 | 5.01 Million USD | 30.52% |
| 2011 Q3 | 3.84 Million USD | -23.57% |
| 2011 Q2 | 5.02 Million USD | 256.27% |
| 2011 Q1 | -3.21 Million USD | -163.32% |
| 2010 FY | - USD | 112.35% |
| 2010 Q1 | 2.44 Million USD | -42.99% |
| 2010 Q2 | 4.48 Million USD | 83.32% |
| 2010 Q3 | 4.56 Million USD | 1.79% |
| 2010 Q4 | 5.08 Million USD | 11.36% |
| 2009 FY | - USD | -35.49% |
| 2009 Q2 | 1.63 Million USD | 29.02% |
| 2009 Q1 | 1.26 Million USD | -62.81% |
| 2009 Q4 | 4.28 Million USD | 38.0% |
| 2009 Q3 | 3.1 Million USD | 89.94% |
| 2008 FY | - USD | 26.42% |
| 2008 Q2 | 3.4 Million USD | 24.89% |
| 2008 Q1 | 2.72 Million USD | -27.18% |
| 2008 Q4 | 3.41 Million USD | 8.49% |
| 2008 Q3 | 3.14 Million USD | -7.59% |
| 2007 Q4 | 3.74 Million USD | 68.97% |
| 2007 FY | - USD | 23.47% |
| 2007 Q3 | 2.21 Million USD | -8.5% |
| 2007 Q2 | 2.41 Million USD | 46.02% |
| 2007 Q1 | 1.65 Million USD | -29.26% |
| 2006 FY | - USD | 60.02% |
| 2006 Q4 | 2.34 Million USD | 45.27% |
| 2006 Q3 | 1.61 Million USD | -25.87% |
| 2006 Q2 | 2.17 Million USD | 9.07% |
| 2006 Q1 | 1.99 Million USD | 20.68% |
| 2005 Q3 | 743.01 Thousand USD | -49.98% |
| 2005 Q4 | 1.65 Million USD | 122.38% |
| 2005 Q2 | 1.48 Million USD | 24.18% |
| 2005 Q1 | 1.19 Million USD | -22.11% |
| 2005 FY | - USD | 24.5% |
| 2004 Q4 | 1.53 Million USD | 192.31% |
| 2004 FY | - USD | 1.77% |
| 2004 Q2 | 1.13 Million USD | 29.24% |
| 2004 Q1 | 879.75 Thousand USD | -59.15% |
| 2004 Q3 | 525.34 Thousand USD | -53.79% |
| 2003 Q1 | 226.36 Thousand USD | -78.67% |
| 2003 FY | - USD | 27.02% |
| 2003 Q4 | 713.76 Thousand USD | 136.93% |
| 2003 Q3 | 908.88 Thousand USD | 20.71% |
| 2003 Q2 | 753.94 Thousand USD | 292.86% |
| 2002 Q1 | 385.48 Thousand USD | -69.79% |
| 2002 Q4 | 882.87 Thousand USD | 9.44% |
| 2002 FY | - USD | 96.94% |
| 2002 Q3 | 820.85 Thousand USD | -21.82% |
| 2002 Q2 | 355.92 Thousand USD | 172.36% |
| 2001 Q3 | -694.13 Thousand USD | -209.93% |
| 2001 FY | - USD | -75.83% |
| 2001 Q1 | 388.5 Thousand USD | -80.35% |
| 2001 Q2 | 647.82 Thousand USD | 62.53% |
| 2001 Q4 | 217.5 Thousand USD | 283.83% |
| 2000 Q4 | 1.87 Million USD | 29.79% |
| 2000 Q3 | 1.52 Million USD | -10.89% |
| 2000 Q2 | 1.65 Million USD | 20.79% |
| 2000 Q1 | 1.41 Million USD | -16.74% |
| 2000 FY | - USD | 22.75% |
| 1999 Q3 | 1.1 Million USD | -26.67% |
| 1999 Q2 | 1.5 Million USD | 25.0% |
| 1999 Q1 | 1.2 Million USD | -25.0% |
| 1999 FY | - USD | 5.88% |
| 1999 Q4 | 1.7 Million USD | 54.55% |
| 1998 Q1 | 1 Million USD | -37.5% |
| 1998 Q2 | 1.1 Million USD | 10.0% |
| 1998 Q3 | 1.5 Million USD | 36.36% |
| 1998 Q4 | 1.6 Million USD | 6.67% |
| 1998 FY | - USD | 6.25% |
| 1997 FY | - USD | 33.33% |
| 1997 Q2 | 1 Million USD | 11.11% |
| 1997 Q3 | 1.2 Million USD | 20.0% |
| 1997 Q1 | 900 Thousand USD | -18.18% |
| 1997 Q4 | 1.6 Million USD | 33.33% |
| 1996 Q2 | 900 Thousand USD | 28.57% |
| 1996 FY | - USD | 50.0% |
| 1996 Q3 | 1 Million USD | 11.11% |
| 1996 Q4 | 1.1 Million USD | 10.0% |
| 1996 Q1 | 700 Thousand USD | 0.0% |
| 1995 Q3 | 700 Thousand USD | 40.0% |
| 1995 Q4 | 700 Thousand USD | 0.0% |
| 1995 Q1 | 400 Thousand USD | 140.0% |
| 1995 Q2 | 500 Thousand USD | 25.0% |
| 1995 FY | - USD | 200.0% |
| 1994 Q3 | 100 Thousand USD | 200.0% |
| 1994 Q1 | -100 Thousand USD | 99.54% |
| 1994 Q2 | - USD | 0.0% |
| 1994 FY | - USD | -46.67% |
| 1994 Q4 | - USD | -1100.0% |
| 1993 Q1 | 7.5 Million USD | 136.06% |
| 1993 Q2 | 7.5 Million USD | 0.0% |
| 1993 Q3 | 7.6 Million USD | 1.33% |
| 1993 Q4 | -21.7 Million USD | -385.53% |
| 1993 FY | - USD | -6.25% |
| 1992 Q3 | 7.3 Million USD | 0.0% |
| 1992 FY | - USD | -23.81% |
| 1992 Q4 | -20.8 Million USD | -384.93% |
| 1992 Q1 | 7.3 Million USD | 137.06% |
| 1992 Q2 | 7.3 Million USD | 0.0% |
| 1991 Q4 | -19.7 Million USD | -381.43% |
| 1991 FY | - USD | 0.0% |
| 1991 Q1 | 7 Million USD | 0.0% |
| 1991 Q2 | 7 Million USD | 0.0% |
| 1991 Q3 | 7 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 639.356% |
| Cerus Corporation | -26.53 Million USD | 374.129% |
| OrthoPediatrics Corp. | -8.38 Million USD | 967.951% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 793.154% |
| Talis Biomedical Corporation | -66.04 Million USD | 210.142% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 536.24% |
| Inogen, Inc. | -45.67 Million USD | 259.248% |
| Spectral AI, Inc. | -12.26 Million USD | 693.239% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 252.523% |
| CVRx, Inc. | -38.73 Million USD | 287.816% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 2161.876% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 700.834% |
| Orthofix Medical Inc. | -86.98 Million USD | 183.627% |
| Venus Concept Inc. | -26.11 Million USD | 378.57% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 246.155% |
| Bioventus Inc. | -23.07 Million USD | 415.314% |
| BrainsWay Ltd. | -2.31 Million USD | 3247.685% |
| Envoy Medical, Inc. | -18.23 Million USD | 498.854% |
| electroCore, Inc. | -17.76 Million USD | 509.589% |
| IceCure Medical Ltd | -15.25 Million USD | 576.909% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 246.214% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 531.563% |
| MaxCyte, Inc. | -44.12 Million USD | 264.845% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 718.774% |
| Nexalin Technology, Inc. | -5.69 Million USD | 1377.977% |
| PAVmed Inc | -75.74 Million USD | 196.041% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 235.316% |
| RxSight, Inc. | -41.03 Million USD | 277.262% |
| Sight Sciences, Inc. | -49.41 Million USD | 247.208% |
| SI-BONE, Inc. | -34.44 Million USD | 311.18% |
| TELA Bio, Inc. | -40.63 Million USD | 279.024% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 224.778% |
| Treace Medical Concepts, Inc. | -39 Million USD | 286.482% |
| LivaNova PLC | 39.01 Million USD | -86.444% |
| 908 Devices Inc. | -34.02 Million USD | 313.793% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 165.776% |
| Nemaura Medical Inc. | -7.28 Million USD | 1098.249% |
| NeuroPace, Inc. | -22.83 Million USD | 418.573% |
| LENSAR, Inc. | -8.71 Million USD | 934.783% |
| Apyx Medical Corporation | -18.11 Million USD | 501.629% |
| Cutera, Inc. | -136.56 Million USD | 153.268% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 2252.16% |
| BioSig Technologies, Inc. | -28.15 Million USD | 358.403% |
| Anika Therapeutics, Inc. | 2.51 Million USD | -2791.216% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 446.577% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 81.035% |
| Axonics, Inc. | 7.77 Million USD | -835.601% |
| Outset Medical, Inc. | -153.78 Million USD | 147.301% |
| IRIDEX Corporation | -7.44 Million USD | 1076.678% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 174.156% |
| IRadimed Corporation | 20.8 Million USD | -249.715% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 1002.295% |
| INVO Bioscience, Inc. | -6.88 Million USD | 1157.308% |
| Telesis Bio, Inc. | -40.49 Million USD | 279.643% |
| Viemed Healthcare, Inc. | 36.67 Million USD | -98.334% |
| Varex Imaging Corporation | 67.2 Million USD | -8.249% |
| Quipt Home Medical Corp. | 44.07 Million USD | -65.059% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 769.209% |
| Pulmonx Corporation | -55.09 Million USD | 232.039% |
| Dynatronics Corporation | -976 Thousand USD | 7553.115% |
| Modular Medical, Inc. | -17.1 Million USD | 525.323% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 602.195% |
| Semler Scientific, Inc. | 23.58 Million USD | -208.377% |
| InMode Ltd. | 196.28 Million USD | 62.94% |
| Bruker Corporation | 599 Million USD | 87.856% |
| Cytosorbents Corporation | -28.81 Million USD | 352.485% |
| DexCom, Inc. | 916.7 Million USD | 92.065% |
| Align Technology, Inc. | 799.03 Million USD | 90.896% |
| Viveve Medical, Inc. | -20.61 Million USD | 452.83% |
| ZimVie Inc. | 91.07 Million USD | 20.127% |
| Movano Inc. | -29.12 Million USD | 349.761% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 1750.25% |
| Nexalin Technology, Inc. | -5.69 Million USD | 1377.977% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 2161.876% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 137.37% |
| Profound Medical Corp. | -27.12 Million USD | 368.192% |
| Insulet Corporation | 323.6 Million USD | 77.521% |
| enVVeno Medical Corporation | -25.01 Million USD | 390.763% |
| Surmodics, Inc. | 1.18 Million USD | -6023.148% |
| iCAD, Inc. | -6.56 Million USD | 1208.043% |
| Nuwellis, Inc. | -16.35 Million USD | 544.748% |
| Biotricity, Inc. | -8.82 Million USD | 923.978% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 175.1% |
| Aethlon Medical, Inc. | -11.84 Million USD | 713.911% |
| InspireMD, Inc. | -20.91 Million USD | 447.87% |
| PAVmed Inc. | -75.74 Million USD | 196.041% |
| BIOLASE, Inc. | -15.13 Million USD | 580.501% |
| Beyond Air, Inc. | -59.03 Million USD | 223.228% |
| FONAR Corporation | 28.25 Million USD | -157.483% |
| AxoGen, Inc. | -13.32 Million USD | 645.791% |
| Vivani Medical, Inc. | -26.6 Million USD | 373.388% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | -196.414% |
| Inari Medical, Inc. | 7.11 Million USD | -922.677% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 2248.482% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 1281.661% |
| Tenon Medical, Inc. | -15.52 Million USD | 568.463% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 576.503% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 275.387% |
| AdaptHealth Corp. | -171.09 Million USD | 142.517% |
| Sintx Technologies, Inc. | -6.6 Million USD | 1202.167% |
| NanoVibronix, Inc. | -3.43 Million USD | 2217.7% |
| Quanterix Corporation | -38.08 Million USD | 290.987% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 769.209% |
| Sensus Healthcare, Inc. | 30 Thousand USD | -242376.667% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 126.234% |
| TransMedics Group, Inc. | -7.6 Million USD | 1056.767% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 434.22% |
| NeuroMetrix, Inc. | -7.09 Million USD | 1125.154% |
| Hyperfine, Inc. | -47.06 Million USD | 254.572% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 224.759% |
| Biomerica, Inc. | -5.99 Million USD | 1313.799% |
| Bone Biologics Corporation | 479.57 Thousand USD | -15068.317% |
| AVITA Medical, Inc. | -39.56 Million USD | 283.844% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 893.018% |
| Silk Road Medical, Inc | -45.08 Million USD | 261.364% |